Different expressions of EGF/HGF indicated that activation of EGFR/MET relied on different ways in vivo and higher levels of HGF in HCC tissue allowed MET to play an important role in the regulation of the Ras/MAPK pathway. The gene discussed is EGFR; the disease is hepatocellular carcinoma.